Correlation of the cellular proliferation marker index, such as PCNA and Ki-67, with patient survival is also controversial in ovarian cancer (Nakopoulou et al, 1993; Thomas et al, 1995; Itamochi et al, 2002). This evidence concerns the gene PCNA and ovarian carcinoma.